Dramburg Stephanie, Matricardi Paolo Maria, Casper Ingrid, Klimek Ludger
Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Centre for Rhinology and Allergology Wiesbaden, Wiesbaden, Germany.
Allergo J Int. 2021;30(6):193-197. doi: 10.1007/s40629-021-00175-5. Epub 2021 Jun 11.
The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic presented unprecedented challenges to both inpatient and outpatient care. In order to maintain good care under necessary contact restrictions, especially in the outpatient sector, the use of telemedical applications was demanded and promoted. The exploratory survey among members of the Association of German Allergists (AeDA) was intended to show how these were received among allergists in private practice.
The survey was restricted to actively practising members of the AeDA who had previously given their consent to receive such surveys ( = 437). They were invited by email to participate in a survey on the topic of "Telemedicine in everyday clinical practice in allergology". The survey included quantitative and qualitative questions on the use of telemedicine services before and during the pandemic and was conducted anonymously on the SoSci Survey platform. Participation was possible in the period from June to August 2020.
In all, 76 specialists with additional qualification in allergology took part in the survey. Of these, 71 completed the full questionnaire. Before the start of the pandemic-related contact restrictions, 46.5% (33/71) stated that they had used telemedicine in their clinical practice. This number increased to 73.2% (52/71) after 31 January 2020. The largest increase (4.3% vs. 15.6%) was seen in the area of video consultations. Furthermore, 43/76 participants can imagine integrating telemedicine services into their daily clinical routine in the future.
The use of telemedical services, especially video consultations, increased significantly during the SARS-CoV‑2 pandemic in Germany. The majority of respondents perceive the implementation as positive and can imagine continuing to use telemedical methods after the end of the pandemic.
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)大流行给住院和门诊护理带来了前所未有的挑战。为了在必要的接触限制下维持良好的护理,特别是在门诊部门,远程医疗应用的使用受到了需求并得到了推广。对德国过敏症专科医生协会(AeDA)成员进行的探索性调查旨在展示这些应用在私人执业过敏症专科医生中的接受情况。
该调查仅限于AeDA的积极执业成员,他们此前已同意接受此类调查(n = 437)。通过电子邮件邀请他们参与一项关于“过敏症日常临床实践中的远程医疗”主题的调查。该调查包括关于大流行之前和期间远程医疗服务使用情况的定量和定性问题,并在SoSci调查平台上匿名进行。调查于2020年6月至8月期间进行。
共有76名具有过敏症额外资质的专科医生参与了调查。其中,71人完成了完整问卷。在与大流行相关的接触限制开始之前,46.5%(33/71)表示他们在临床实践中使用过远程医疗。在2020年1月31日之后,这一数字增加到了73.2%(52/71)。视频咨询领域的增长最为显著(从4.3%增至15.6%)。此外,43/76的参与者可以想象在未来将远程医疗服务整合到他们的日常临床工作中。
在德国,SARS-CoV-2大流行期间远程医疗服务的使用,尤其是视频咨询,显著增加。大多数受访者认为这种应用是积极的,并可以想象在大流行结束后继续使用远程医疗方法。